Who founded Gensight Biologics S.A?

Gensight Biologics S.A was founded by Bernard Gilly in 2012.

Who are Gensight Biologics S.A's investors?

Gensight Biologics S.A's investors include Sofinnova Partners, Abingworth.

How much funding has Gensight Biologics S.A raised?

Gensight Biologics S.A has disclosed $25M raised across 1 round.

Where is Gensight Biologics S.A headquartered?

Gensight Biologics S.A is headquartered in Paris, FR.

Gensight Biologics S.A

Paris, FR · Founded 2012 · France corporation · 2 known investors

Find your way into Gensight Biologics S.A

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases. The company is pursuing regulatory approval and early access programs in Europe.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Gensight Biologics S.A was founded in 2012 by Bernard Gilly.

Bernard GillyFounder

Jean-Philippe CombalExecutive

Thomas GidoinExecutive

Didier PruneauinExecutive

Nitza ThomassonExecutive

Board

Florent GrosBoard director

Peter GoodfellowBoard directorSenior Advisor at Abingworth

Genghis Lloyd-Harris inBoard directorSenior Advisor at Abingworth

Michael Stephen WyzgaBoard director

Guido MagniBoard director

Investors · 2

Sofinnova PartnersParis · $540K – $27M

Abingworthreported · 2 sourcesLondon · $15M – $30Mvia Genghis Lloyd-Harris · board

Reported raises · per SEC filings

Form D private placements

$25M disclosed across 1 round · 2015

▶$25MraisedJul 2015 · 15 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jean-Philippe CombalExecutive Officer
Michael Stephen WyzgaDirector
Thomas GidoinExecutive Officer
Didier PruneauExecutive Officer
Florent GrosDirector
Nitza ThomassonExecutive Officer
Bernard GillyExecutive Officer, Director
Guido MagniDirector
Peter GoodfellowDirector
Genghis Lloyd-HarrisDirector

Offering amount: $25M
Amount sold: $25M
Sales commissions: $1.3M
Placement agents: Leerink Partners LLC
First sale: Jul 2015
Incorporated: Corporation, France, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Gensight Biologics S.A do?: GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases. The company is pursuing regulatory approval and early access programs in Europe.
Who founded Gensight Biologics S.A?: Gensight Biologics S.A was founded by Bernard Gilly in 2012.
Who are Gensight Biologics S.A's investors?: Gensight Biologics S.A's investors include Sofinnova Partners, Abingworth.
How much funding has Gensight Biologics S.A raised?: Gensight Biologics S.A has disclosed $25M raised across 1 round.
Where is Gensight Biologics S.A headquartered?: Gensight Biologics S.A is headquartered in Paris, FR.